Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Louisa Laidlaw"'
Autor:
Igor I. Rybkin, Michael A. Thompson, Frank M. Wolf, Kristen Collins, Louisa Laidlaw, Tom Mikkelsen, Jennifer Godden, Mary Walters, James L. Weese, Ronda Broome, Joe Burkhart, Veronica Jones, Chenan Zhang, Thomas D. Brown, Anna Berry
Publikováno v:
Molecular Cancer Therapeutics. 20:P159-P159
Background: Molecular tumor boards (MTB) are a key component of most precision oncology programs, designed to provide a structured multidisciplinary approach to evaluating cancer patients (pts) for therapy (Tx), clinical trial (CT) enrollment, and ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d42921c3b5ead4cb3fa01c762fa7471a
https://doi.org/10.1158/1535-7163.targ-21-p159
https://doi.org/10.1158/1535-7163.targ-21-p159
Publikováno v:
Journal of Clinical Oncology. 38:e19266-e19266
e19266 Background: HFHS implemented clinically-oriented Precision Medicine Program (PMP) in 2016. As part of the program, multidisciplinary molecular tumor board (MTB) was created to review complex molecular cases, providing guidance to treating medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c05bc0c4d130c3f7636ce174228b9dd
https://doi.org/10.1200/jco.2020.38.15_suppl.e19266
https://doi.org/10.1200/jco.2020.38.15_suppl.e19266
Autor:
Nadia Z. Haque, Dhananjay Chitale, Louisa Laidlaw, Spencer C. Hoover, Ding Wang, Steven N. Kalkanis, Igor I. Rybkin
Publikováno v:
Journal of Clinical Oncology. 36:e18541-e18541
e18541Background: Advances in precision medicine (PM) offer new promises for cancer care delivery. Genomic analysis provides guidance on selecting molecularly targeted therapies for favorable outco...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eb3b1ceedbb8785d29cad390ec5f932
https://doi.org/10.1200/jco.2018.36.15_suppl.e18541
https://doi.org/10.1200/jco.2018.36.15_suppl.e18541